The acquisition provides Novartis with full rights to IFM Due's portfolio of STING antagonists, which have the potential to treat an array of serious inflammation-driven diseases characterized by excessive interferon and other pro-inflammatory cytokine signaling.
Global Pharma | 13/03/2024 | By Manvi | 462
Casio Introduces DZ-C100 COLPOCAMERA and CST-100M Camera Stand to US, Australia and New Zealand
Alongside the devices, the image management software D'z IMAGE Viewer C is also available in these regions, marking a significant expansion of Casio's medical device offerings.
Global Pharma | 13/03/2024 | By Abha | 581
AstraZeneca India and Mankind Pharma Collaborate to Expand Access to Asthma Treatment Across India
India currently accounts for 13 percent of the global asthma burden and a staggering 43 percent of asthma-related deaths worldwide.
Global Pharma | 13/03/2024 | By Abha | 733
ScreenPoint Medical Deploys Transpara Breast AI at Johns Hopkins to Improve Cancer Detection
The Johns Hopkins Kimmel Cancer Center was one of the first to be recognized by the National Cancer Institute as a 'Center of Excellence.'
Global Pharma | 12/03/2024 | By Manvi | 501
The collaboration aims to significantly accelerate the development and commercialization of Ratio's pipeline of next-generation radiotherapies, representing a critical component in advancing Ratio's fibroblast activation protein-alpha (FAP)-targeted radiotherapeutic candidate.
Global Pharma | 12/03/2024 | By Manvi | 810
Syntegon's SBM Introduces New Sterilizer Series for Pharmaceutical Manufacturers
Christian Dallner, SBM's product manager, highlights the standardized basis of the SBM Essential Line, which promises shorter delivery times and competitive prices for pharmaceutical manufacturers.
Global Pharma | 12/03/2024 | By Abha | 1038
Gennova BioPharma Announces the Launch of HAMSYL Junior
Gennova Biopharmaceuticals Ltd., announces the launch of the India’s first paediatric pack size of pegaspargase – HAMSYL – Junior, which will now be available in a 1500 IU pack size.
Global Pharma | 11/03/2024 | By Manvi | 1212
These are important steps to providing a full suite of ketamine options for customers across the country, and preparation for potential approval of HTX-100 by regulatory authorities worldwide.
Global Pharma | 11/03/2024 | By Manvi | 365
FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Obesity
Obesity and overweight afflict approximately 70 percent of American adults, posing grave health hazards that elevate the likelihood of premature mortality and a spectrum of health ailments, including heart attack and stroke.
Global Pharma | 11/03/2024 | By Abha | 1168
PulseCath Achieves MDR CE Certification for iVAC 2L System
This certification signifies PulseCath's unwavering dedication to upholding the highest standards of quality and safety in medical device technology.
Global Pharma | 11/03/2024 | By Abha | 438
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy